Dr. Mark Kay

Biography

Mark Kay is the Dennis Farrey Family Professor of Pediatrics and a Professor of Genetics at Stanford University, specializing in Human Gene Therapy. He has been an influential figure in gene transfer technologies, focusing on the use of hepatic gene therapy for the treatment of genetic and acquired diseases. His research primarily involves developing new vector systems and delivery methods, investigating appropriate animal models, and uncovering mechanisms involved in vector transduction. He aims to advance promising approaches through clinical trials, working on numerous viral and non-viral vector systems related to major disease models such as hemophilia and hepatitis C. Additionally, Kay's research encompasses the role of small RNAs in mammalian gene regulation. He has received various accolades, including the 2017 Distinguished Alumni Award from Case Western Reserve University and the Pediatric Researcher Year from the E. Mead Johnson Award in 2000. His leadership roles have included serving on the Executive Committee of the Faculty Senate at Stanford and as Chief Scientific Advisor for Benitec, LLC. He has also held several key leadership positions within professional organizations, including the American Society of Gene Therapy.

Research Interests

Experience

Courses